EKF Diagnostics Holdings Plc (EKF)

London
76.40
+2.20(+2.96%)
  • Volume:
    9
  • Bid/Ask:
    74.00/77.20
  • Day's Range:
    76.40 - 76.40

EKF Overview

Prev. Close
74.2
Day's Range
76.4-76.4
Revenue
77.49M
Open
76.4
52 wk Range
59-86.8
EPS
0.04
Volume
9
Market Cap
354.44M
Dividend (Yield)
1.10
(1.47%)
Average Volume (3m)
416,546
P/E Ratio
21.06
Beta
0.69
1-Year Change
17.78%
Shares Outstanding
463,930,564
Next Earnings Date
27 Mar 2022
What is your sentiment on EKF Diagnostics Holdings Plc?
or
Vote to see community's results!

EKF Diagnostics Holdings Plc Company Profile

EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T Low to determine low levels of hemoglobin in plasma and serum specimens, aqueous solutions, or stored or banked erythrocytes; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples. It also provides glucose and lactate analyzers, such as Biosen C-Line GP+ and C-Line Clinic; Quo-Lab A1c, a desktop point-of-care analyzer for measuring glycated hemoglobin; Quo-Test A1c for the monitoring and management of diabetes; and STAT-Site M Beta-hydroxybutyrate analyzer. In addition, it offers Creamatocrit Plus, an analyzer for detecting the lipid concentration and calorific density in mothers’ milk; QuPID and True20 pregnancy tests; and Lactate Scout 4, a lactate analyzer. Further, it offers Altair 240, a chemistry analyzer; Excel, a semi-automated chemistry analyzer; Micro 12, a micro centrifuge for clinical, molecular, and bacteriological applications; Hema-Screen Serology, an analyzer dependent for early detection of colorectal cancer; Uri-Trak 120 urine analyzer; rapid test detectors; QuStick Strep A for Strep A infection treatment; RaPET Serology immunoassay kits; LiquiColor biomarkers; and kits and other services related to COVID-19, as well as reagents, calibrators, standards, and controls. Additionally, it offers contract manufacturing services, as well as distributes third party company's products. It sells its products directly to hospitals, laboratories, and government agencies, as well as through a network of distributors. The company was founded in 1990 and is headquartered in Cardiff, the United Kingdom.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellBuy
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Buy
SummaryStrong SellStrong SellStrong SellStrong SellStrong Buy
  • Looks good value now after the release of its earnings on 21st March.
    0
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.